• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $ITGR

    Integer Holdings Corporation

    Subscribe to $ITGR
    $ITGR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates in two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and management systems, charging and docking stations, and power supplies for the energy, military, and environmental markets. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. The company was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

    IPO Year:

    Exchange: NYSE

    Website: integer.net

    Recent Analyst Ratings for Integer Holdings Corporation

    DatePrice TargetRatingAnalyst
    3/28/2025$145.00Outperform
    Raymond James
    2/21/2025Outperform → Perform
    Oppenheimer
    12/3/2024$160.00Overweight
    Wells Fargo
    7/16/2024$135.00Outperform
    Oppenheimer
    5/15/2024$137.00Buy
    Truist
    4/15/2024$105.00 → $135.00Neutral → Buy
    BofA Securities
    3/14/2024$137.00Buy
    CL King
    2/6/2024$125.00Overweight
    KeyBanc Capital Markets
    5/26/2023$87.00Equal Weight
    Wells Fargo
    5/11/2023$88.00Neutral
    Citigroup
    See more ratings

    Integer Holdings Corporation Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Integer to Present at Bank of America Securities Health Care Conference on May 14

      PLANO, Texas, April 29, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading medical device contract development and manufacturing organization (CDMO), today announced participation in the 2025 Bank of America Securities Health Care Conference, to be held May 13-15, 2025, in Las Vegas. Members of the Integer executive leadership team will participate in a fireside chat on Wednesday, May 14, at 10:00 a.m. PT. A live webcast of the presentation will be accessible under "News & Events" on the Investor Relations section of the Integer website at investor.integer.net. Learn more about Integer at www.integer.net. About Integer®Integer Holdings Corporation (NYSE:I

      4/29/25 8:00:00 AM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Integer Announces CEO Succession Plan

      ~ Joseph Dziedzic to retire as President and CEO ~~ Payman Khales appointed President and CEO effective October 24, 2025 ~ PLANO, Texas, April 24, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading medical device contract development and manufacturing organization, today announced that Joseph Dziedzic will retire as President and Chief Executive Officer and will step down from the Board of Directors, effective October 24, 2025. At that time, Payman Khales, Chief Operating Officer, will assume the President and CEO position and join the Company's Board. To ensure a smooth transition, Mr. Dziedzic will serve as an advisor to the Company through March 31, 2026. "We

      4/24/25 8:01:00 AM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Integer Holdings Corporation Reports First Quarter 2025 Results

      ~ Strong start to the year with 1Q25 financial results ~~ Reiterating 2025 sales and adjusted operating income outlook; raising adjusted EPS outlook ~ PLANO, Texas, April 24, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) today announced results for the three months ended March 28, 2025.   First Quarter 2025 Highlights (compared to First Quarter 2024, except as noted) Sales increased 7% to $437 million, with organic growth of 6%.GAAP operating income increased $11 million to $50 million, an increase of 28%. Non-GAAP adjusted operating income increased $9 million to $71 million, an increase of 14%.GAAP income (loss) from continuing operations decreased $43 million to a

      4/24/25 8:00:00 AM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Integer Holdings Corporation Issues Statement on Tariffs

      PLANO, Texas, April 11, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading contract development and manufacturing organization, issued a statement on the impact of tariffs on its business given the recent extraordinary developments regarding trade policies. "We continue to estimate an impact of $1 to $5 million on full year adjusted operating income, consistent with previous communications. This estimate assumes currently applicable tariffs as well as the additional tariffs that were announced on April 2 by the U.S. that would take effect following the 90-day pause. This estimate also incorporates implemented and planned mitigation actions," said Joseph Dziedzic,

      4/11/25 7:00:00 AM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Integer Holdings Corporation Announces Conversion Period for 2.125% Convertible Senior Notes due 2028

      PLANO, Texas, April 02, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) ("Integer" or the "Company"), a leading medical device contract development and manufacturing organization, today notified holders of its 2.125% Convertible Senior Notes due 2028 (the "Notes") that the Notes are convertible, at the option of the holders (the "Conversion Option") beginning on April 1, 2025, and ending at the close of business on June 30, 2025. The Notes are convertible into cash, up to the principal amount of the Notes, and in cash, shares of the Company's common stock or a combination thereof, at the Company's election, in respect of the remainder, if any, of the Company's conversion

      4/2/25 4:05:00 PM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Integer Schedules First Quarter 2025 Earnings Release and Conference Call for April 24, 2025

      PLANO, Texas, March 27, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that it plans to release financial and operational results for first quarter 2025 at 7 a.m. Central Time (CT) / 8 a.m. Eastern Time (ET) on Thursday, April 24, 2025. Following the release, Integer management will host a webcast at 8 a.m. CT / 9 a.m. ET to discuss these results. Other forward-looking and material information may also be discussed during this call. Conference call details: Date: Thursday, April 24, 2025Time: 8 a.m. CT / 9 a.m. ETDomestic dial-in number: (800) 715-9871International dial-in number: (646) 307-1963Conference ID: 3120125Webcast Registration: ITGR Q1 2025 Ea

      3/27/25 8:00:00 AM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Integer Holdings Corporation Enhances Capitalization Structure with the Closing of $1.0 Billion Convertible Senior Notes Offering

      ~ Strategic transaction to create revolver capacity ~~ Immediately accretive to 2025 adjusted earnings on meaningfully lower interest expense ~ PLANO, Texas, March 18, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (the "Company") (NYSE:ITGR), a leading medical device contract development and manufacturing organization, announces the closing of its offering of $1.0 billion aggregate principal amount of 1.875% convertible senior notes due 2030 (the "Notes"). In response to strong investor demand at attractive terms, the Company upsized the initial offering of $750 million aggregate principal amount of the Notes to $875 million and the initial purchasers fully exercised their o

      3/18/25 9:30:46 PM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Integer Holdings Corporation Announces Upsize and Pricing of Convertible Notes Offering

      PLANO, Texas, March 13, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (the "Company," "Integer") (NYSE:ITGR) today announced that it has priced an offering of $875.0 million aggregate principal amount of 1.875% convertible senior notes due 2030 (the "Convertible Notes"). The offering was upsized from the previously announced offering size of $750.0 million aggregate principal amount of Convertible Notes. The Company granted to the initial purchasers of the Convertible Notes an option to purchase up to an additional $125.0 million aggregate principal amount of the Convertible Notes for settlement within a 13-day period beginning on, and including, the first day on which the Convert

      3/13/25 11:29:46 PM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Integer Holdings Corporation Announces Launch of Convertible Notes Offering

      PLANO, Texas, March 12, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (the "Company," "Integer") (NYSE:ITGR) today announced that it intends to offer, subject to market and other conditions, $750.0 million aggregate principal amount of its convertible senior notes due 2030 (the "Convertible Notes"). The Company also intends to grant to the initial purchasers of the Convertible Notes an option to purchase up to an additional $125.0 million aggregate principal amount of the Convertible Notes for settlement within a 13-day period beginning on, and including, the first day on which the Convertible Notes are issued. In connection with the pricing of the Convertible Notes, the Company

      3/12/25 4:05:00 PM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Integer Holdings Corporation Reports Results for Fourth Quarter and Full Year 2024

      ~ Strong 4Q and Full Year sales and profit increase versus last year ~ ~ Expect 8% to 10% sales growth in 2025 with expanding margins ~ PLANO, Texas, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading contract development and manufacturing organization, today announced results for the three and twelve months ended December 31, 2024. Unless otherwise stated, all results and comparisons are from continuing operations. Fourth Quarter 2024 Financial Results (compared to fourth quarter 2023, except as noted) Sales increased 11% to $449 million.GAAP income from continuing operations increased $6 million to $33 million, an increase of 23%. Adjusted net incom

      2/20/25 8:00:00 AM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    Integer Holdings Corporation SEC Filings

    See more
    • SEC Form 10-Q filed by Integer Holdings Corporation

      10-Q - Integer Holdings Corp (0001114483) (Filer)

      4/24/25 5:12:21 PM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Integer Holdings Corporation filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Integer Holdings Corp (0001114483) (Filer)

      4/24/25 4:00:10 PM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Integer Holdings Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Integer Holdings Corp (0001114483) (Filer)

      4/24/25 8:07:31 AM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Amendment: SEC Form SCHEDULE 13G/A filed by Integer Holdings Corporation

      SCHEDULE 13G/A - Integer Holdings Corp (0001114483) (Subject)

      4/15/25 12:18:00 PM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Integer Holdings Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Integer Holdings Corp (0001114483) (Filer)

      4/11/25 7:06:54 AM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form DEFA14A filed by Integer Holdings Corporation

      DEFA14A - Integer Holdings Corp (0001114483) (Filer)

      4/7/25 4:23:00 PM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form DEF 14A filed by Integer Holdings Corporation

      DEF 14A - Integer Holdings Corp (0001114483) (Filer)

      4/7/25 4:21:08 PM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Integer Holdings Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - Integer Holdings Corp (0001114483) (Filer)

      4/2/25 4:27:30 PM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Integer Holdings Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Integer Holdings Corp (0001114483) (Filer)

      3/19/25 7:00:14 AM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form PRE 14A filed by Integer Holdings Corporation

      PRE 14A - Integer Holdings Corp (0001114483) (Filer)

      3/18/25 5:25:16 PM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    Integer Holdings Corporation Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more

    Integer Holdings Corporation Leadership Updates

    Live Leadership Updates

    See more

    Integer Holdings Corporation Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • President, CRM & Neuro Stephens Jim converted options into 491 shares and covered exercise/tax liability with 120 shares, increasing direct ownership by 41% to 1,274 units (SEC Form 4)

      4 - Integer Holdings Corp (0001114483) (Issuer)

      5/16/25 4:12:35 PM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form 3 filed by new insider Carr Terence

      3 - Integer Holdings Corp (0001114483) (Issuer)

      5/15/25 8:06:24 PM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • EVP, Chief Financial Officer Smith Diron converted options into 2,063 shares and covered exercise/tax liability with 706 shares, increasing direct ownership by 26% to 6,582 units (SEC Form 4)

      4 - Integer Holdings Corp (0001114483) (Issuer)

      5/12/25 4:59:27 PM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • President & CEO Dziedzic Joseph W exercised 71,384 shares at a strike of $43.72, sold $41,751,433 worth of shares (338,975 units at $123.17) and gifted 24,000 shares, decreasing direct ownership by 93% to 23,000 units (SEC Form 4)

      4 - Integer Holdings Corp (0001114483) (Issuer)

      5/2/25 7:52:35 PM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form 4 filed by SVP, Investor Relations Arora Sanjiv

      4 - Integer Holdings Corp (0001114483) (Issuer)

      4/9/25 5:18:24 PM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form 3 filed by new insider Arora Sanjiv

      3 - Integer Holdings Corp (0001114483) (Issuer)

      4/9/25 5:16:03 PM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form 4 filed by SVP, Gen Counsel & Secretary Blackwood Lindsay K.

      4 - Integer Holdings Corp (0001114483) (Issuer)

      3/26/25 5:51:58 PM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form 3 filed by new insider Blackwood Lindsay K.

      3 - Integer Holdings Corp (0001114483) (Issuer)

      3/26/25 5:48:28 PM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • President & CEO Dziedzic Joseph W converted options into 36,202 shares and covered exercise/tax liability with 13,395 shares, increasing direct ownership by 8% to 314,591 units (SEC Form 4)

      4 - Integer Holdings Corp (0001114483) (Issuer)

      3/13/25 8:04:54 PM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SVP, Strategy and Business Dev Senn Andrew was granted 4,000 shares and covered exercise/tax liability with 1,225 shares, increasing direct ownership by 42% to 9,408 units (SEC Form 4)

      4 - Integer Holdings Corp (0001114483) (Issuer)

      2/25/25 5:17:49 PM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Eargo Announces Strategic Additions to Board of Directors Following Patient Square Capital Becoming New Majority Shareholder

      SAN JOSE, Calif., Dec. 07, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. ("Eargo" or the "Company") (NASDAQ:EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, today announced the appointments of several new directors following the closing of the Company's rights offering as previously announced on November 29, 2022. Patient Square Capital became the Company's majority owner upon closing of the rights offering and conversion of Patient Square's senior secured convertible notes per its investment in June 2022. As previously announced, following the completion of the rights offering, Patient Square has the right to nominate a number of directors t

      12/7/22 4:05:00 PM ET
      $EAR
      $ITGR
      $VAPO
      Medical Specialities
      Health Care
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Medical/Dental Instruments
    • Integer Announces Board Leadership Transition

      PLANO, Texas, March 17, 2022 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource (MDO) manufacturer, announced today that Bill R. Sanford will be retiring as Chair of the Integer Board of Directors at the conclusion of the Company's 2022 annual meeting of stockholders, which is scheduled to be held on May 18, 2022. Commensurate with this carefully planned transition, the Board of Directors plans to appoint current long-standing Integer Board member Pamela G. Bailey to serve as the next Chair of the Board. "On behalf of the Integer Board of Directors, I wish to thank Bill for his immense contribution and insightful leadership over the past 22 ye

      3/17/22 8:00:00 AM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Raymond James initiated coverage on Integer Holdings with a new price target

      Raymond James initiated coverage of Integer Holdings with a rating of Outperform and set a new price target of $145.00

      3/28/25 8:19:38 AM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Integer Holdings downgraded by Oppenheimer

      Oppenheimer downgraded Integer Holdings from Outperform to Perform

      2/21/25 6:56:47 AM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Wells Fargo resumed coverage on Integer Holdings with a new price target

      Wells Fargo resumed coverage of Integer Holdings with a rating of Overweight and set a new price target of $160.00

      12/3/24 7:34:30 AM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Oppenheimer initiated coverage on Integer Holdings with a new price target

      Oppenheimer initiated coverage of Integer Holdings with a rating of Outperform and set a new price target of $135.00

      7/16/24 7:39:49 AM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Truist initiated coverage on Integer Holdings with a new price target

      Truist initiated coverage of Integer Holdings with a rating of Buy and set a new price target of $137.00

      5/15/24 7:34:41 AM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Integer Holdings upgraded by BofA Securities with a new price target

      BofA Securities upgraded Integer Holdings from Neutral to Buy and set a new price target of $135.00 from $105.00 previously

      4/15/24 7:44:16 AM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • CL King initiated coverage on Integer Holdings with a new price target

      CL King initiated coverage of Integer Holdings with a rating of Buy and set a new price target of $137.00

      3/14/24 8:10:11 AM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • KeyBanc Capital Markets resumed coverage on Integer Holdings with a new price target

      KeyBanc Capital Markets resumed coverage of Integer Holdings with a rating of Overweight and set a new price target of $125.00

      2/6/24 6:29:12 AM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Wells Fargo initiated coverage on Integer Holdings with a new price target

      Wells Fargo initiated coverage of Integer Holdings with a rating of Equal Weight and set a new price target of $87.00

      5/26/23 7:32:43 AM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Citigroup initiated coverage on Integer Holdings with a new price target

      Citigroup initiated coverage of Integer Holdings with a rating of Neutral and set a new price target of $88.00

      5/11/23 6:56:12 AM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    Integer Holdings Corporation Financials

    Live finance-specific insights

    See more
    • Integer Announces CEO Succession Plan

      ~ Joseph Dziedzic to retire as President and CEO ~~ Payman Khales appointed President and CEO effective October 24, 2025 ~ PLANO, Texas, April 24, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading medical device contract development and manufacturing organization, today announced that Joseph Dziedzic will retire as President and Chief Executive Officer and will step down from the Board of Directors, effective October 24, 2025. At that time, Payman Khales, Chief Operating Officer, will assume the President and CEO position and join the Company's Board. To ensure a smooth transition, Mr. Dziedzic will serve as an advisor to the Company through March 31, 2026. "We

      4/24/25 8:01:00 AM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Integer Holdings Corporation Reports First Quarter 2025 Results

      ~ Strong start to the year with 1Q25 financial results ~~ Reiterating 2025 sales and adjusted operating income outlook; raising adjusted EPS outlook ~ PLANO, Texas, April 24, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) today announced results for the three months ended March 28, 2025.   First Quarter 2025 Highlights (compared to First Quarter 2024, except as noted) Sales increased 7% to $437 million, with organic growth of 6%.GAAP operating income increased $11 million to $50 million, an increase of 28%. Non-GAAP adjusted operating income increased $9 million to $71 million, an increase of 14%.GAAP income (loss) from continuing operations decreased $43 million to a

      4/24/25 8:00:00 AM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Integer Schedules First Quarter 2025 Earnings Release and Conference Call for April 24, 2025

      PLANO, Texas, March 27, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that it plans to release financial and operational results for first quarter 2025 at 7 a.m. Central Time (CT) / 8 a.m. Eastern Time (ET) on Thursday, April 24, 2025. Following the release, Integer management will host a webcast at 8 a.m. CT / 9 a.m. ET to discuss these results. Other forward-looking and material information may also be discussed during this call. Conference call details: Date: Thursday, April 24, 2025Time: 8 a.m. CT / 9 a.m. ETDomestic dial-in number: (800) 715-9871International dial-in number: (646) 307-1963Conference ID: 3120125Webcast Registration: ITGR Q1 2025 Ea

      3/27/25 8:00:00 AM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Integer Holdings Corporation Reports Results for Fourth Quarter and Full Year 2024

      ~ Strong 4Q and Full Year sales and profit increase versus last year ~ ~ Expect 8% to 10% sales growth in 2025 with expanding margins ~ PLANO, Texas, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading contract development and manufacturing organization, today announced results for the three and twelve months ended December 31, 2024. Unless otherwise stated, all results and comparisons are from continuing operations. Fourth Quarter 2024 Financial Results (compared to fourth quarter 2023, except as noted) Sales increased 11% to $449 million.GAAP income from continuing operations increased $6 million to $33 million, an increase of 23%. Adjusted net incom

      2/20/25 8:00:00 AM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Integer Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call for February 20, 2025

      PLANO, Texas, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that it plans to release financial and operational results for fourth quarter and full year 2024 at 7 a.m. Central Time (CT) / 8 a.m. Eastern Time (ET) on Thursday, February 20, 2025. Following the release, Integer management will host a webcast at 8 a.m. CT / 9 a.m. ET to discuss these results. Other forward-looking and material information may also be discussed during this call. Conference call details: Date: Thursday, February 20, 2025Time: 8 a.m. CT / 9 a.m. ETDomestic dial-in number: (800) 715-9871International dial-in number: (646) 307-1963Conference ID: 3120125Webcast Regis

      1/23/25 8:00:00 AM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Integer Holdings Corporation Reports Third Quarter 2024 Results

        ~ Continued strong performance with 3Q24 financial results ~~ Raising midpoint of 2024 operating profit and EPS outlook ~ PLANO, Texas, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) today announced results for the three and nine months ended September 27, 2024. Our previously announced sale of the Electrochem business for $50 million in cash remains on track and is expected to close later this month. Except for cash flow measures, prior period amounts have been recast to exclude the Electrochem business, which is a discontinued operation, consistent with GAAP continuing operations presentation. Unless otherwise stated, all results and comparisons set forth

      10/24/24 8:00:00 AM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Integer Schedules Third Quarter 2024 Earnings Release and Conference Call for October 24, 2024

      PLANO, Texas, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that it plans to release financial and operational results for third quarter 2024 at 7 a.m. Central Time (CT) / 8 a.m. Eastern Time (ET) on Thursday, October 24, 2024. Following the release, Integer management will host a webcast at 8 a.m. CT / 9 a.m. ET to discuss these results. Other forward-looking and material information may also be discussed during this call. Conference call details: Date: Thursday, October 24, 2024Time: 8 a.m. CT / 9 a.m. ETDomestic dial-in number: (800) 715-9871International dial-in number: (646) 307-1963Conference ID: 4525826Webcast Registration: Q3 2024 Int

      9/26/24 8:00:00 AM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Integer Holdings Corporation Reports Second Quarter 2024 Results

      ~ Continued strong performance with 2Q24 financial results ~~ Raising full year 2024 profit outlook ~ PLANO, Texas, July 25, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) today announced results for the three months ended June 28, 2024. Second Quarter 2024 Highlights (compared to Second Quarter 2023, except as noted) Sales increased 9% to $436 million, with organic growth of 5%.GAAP net income increased $7 million to $31 million, an increase of 30%. Non-GAAP adjusted net income increased $7 million to $45 million, an increase of 17%.GAAP operating income increased $14 million to $55 million, an increase of 33%. Non-GAAP adjusted operating income increased $12

      7/25/24 8:00:00 AM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Integer Schedules Second Quarter 2024 Earnings Release and Conference Call for July 25, 2024

      PLANO, Texas, June 27, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that it plans to release financial and operational results for second quarter 2024 at 7 a.m. Central Time (CT) / 8 a.m. Eastern Time (ET) on Thursday, July 25, 2024. Following the release, Integer management will host a webcast at 8 a.m. CT / 9 a.m. ET to discuss these results. Other forward-looking and material information may also be discussed during this call. Conference call details: Date: Thursday, July 25, 2024Time: 8 a.m. CT / 9 a.m. ETDomestic dial-in number: (800) 715-9871International dial-in number: (646) 307-1963Conference ID: 4525826Webcast Registration: Q2 2024 Integer H

      6/27/24 4:00:00 PM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Integer Holdings Corporation Reports First Quarter 2024 Results

      ~ Strong start to the year with 1Q24 financial results ~~ Reiterate 2024 financial outlook ~ PLANO, Texas, April 25, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) today announced results for the three months ended March 29, 2024. First Quarter 2024 Highlights (compared to First Quarter 2023, except as noted) Sales increased 10% to $415 million, with organic growth of 6%.GAAP net income increased $7 million to $21 million, an increase of 57%. Non-GAAP adjusted net income increased $10 million to $39 million, an increase of 33%.GAAP operating income increased $5 million to $39 million, an increase of 15%. Non-GAAP adjusted operating income increased $13 mil

      4/25/24 8:00:00 AM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    Integer Holdings Corporation Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Integer Holdings Corporation (Amendment)

      SC 13G/A - Integer Holdings Corp (0001114483) (Subject)

      2/9/24 9:59:01 AM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form SC 13G/A filed by Integer Holdings Corporation (Amendment)

      SC 13G/A - Integer Holdings Corp (0001114483) (Subject)

      1/30/24 1:15:44 PM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form SC 13G/A filed by Integer Holdings Corporation (Amendment)

      SC 13G/A - Integer Holdings Corp (0001114483) (Subject)

      2/10/23 2:42:23 PM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form SC 13G filed by Integer Holdings Corporation

      SC 13G - Integer Holdings Corp (0001114483) (Subject)

      1/31/23 11:42:03 AM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form SC 13G/A filed by Integer Holdings Corporation (Amendment)

      SC 13G/A - Integer Holdings Corp (0001114483) (Subject)

      2/10/22 8:17:17 AM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form SC 13G/A filed

      SC 13G/A - Integer Holdings Corp (0001114483) (Subject)

      2/12/21 3:20:51 PM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form SC 13G/A filed

      SC 13G/A - Integer Holdings Corp (0001114483) (Subject)

      2/10/21 11:03:22 AM ET
      $ITGR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care